Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Immunologic Impact of Dupilumab on the Unified Airway System in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps

NCT06556264 is registered in ClinicalTrials.gov with Dr. Andrew Thamboo, MD as lead sponsor.

NCT NCT06556264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06556264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Immunologic Impact of Dupilumab on the Unified Airway System in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps
Lead sponsor
Dr. Andrew Thamboo, MD
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 31, 2024
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic rhinosinusitis with nasal polyps